baber/WOPTO huggingface dataset:
Patent NZ-553322-A (NZ)
Title: Furamate of 4-( (4-( (4- (2-cyanoethenyl) -2,6-dimethylphenyl)amino)-2-pyrimidinyl)amino)benzonitrile, also named TMC278
Inventor: VANDECRUYS ROGER PETRUS GEREBERN
IPC: A61K31/505
Filed: 2005-09-02
Abstract: Disclosed is the fumarate salt of 4-((4-((4-(2-cyanoethenyl)-2,6-dimethylphenyl)amino)-2-pyrimidinyl)amino)benzonitrile, also known as TMC278. The compound is useful for the treatment of HIV infections.
Patent NZ-554578-A (NZ)
Title: A thermo-coating used in carpet and other floor covering
Inventor: JONES RONALD DAVID
Filed: 2004-10-22
Abstract: Disclosed is a thermo-coating adapted for use in flooring formed from at least: an amorphous poly-alpha-olefin; and a hydrocarbon resin selected from cycloaliphatic hydrocarbon resins, polyterpene resins, phenolic resins and/or tall oil rosin; wherein the thermo-coating is recyclable. The thermo-coating is substantially impervious to aqueous liquids. The thermo-coating may be provided as a tape, panel, tile, layer, laminate or the like for covering floor surface material including carpet or any other form of floor covering.
Patent NZ-556435-A (NZ)
Title: Bendamustine pharmaceutical compositions for lyophilisation
Inventor: BRITTAIN JASON EDWARD
IPC: A61K9/19
Filed: 2006-01-13
Abstract: Disclosed is a lyophilized pharmaceutical composition of bendamustine or bendamustine hydrochloride containing not more than about 0.9 percent (area percent of bendamustine as determined using HPLC) of HP1 ((4-{5-[(2-chloroethyl),(2-hydroxyethyl)amino]-1-methyl2-benzimidazolyl}butyric acid) wherein said HP1 is the amount of HP1 present at time zero after reconstitution of a lyophilized preparation of bendamustine or bendamustine hydrochloride. Also disclosed is a method to prepare said composition, use of said composition in the treatment of conditions e.g. Hodgkin's disease and cancer.
Patent NZ-560464-A (NZ)
Title: Secure bootstrapping for wireless communications
Inventor: ROSE GREGORY GORDON
IPC: H04L12/56
Filed: 2006-02-03
Abstract: A method for authenticating a legacy mobile terminal to communicate with a network application function is disclosed. The method comprises: - generating an authentication challenge at a bootstrapping server function, including a first random number as a first parameter, a public key based at least in part on the first random number, and a signature based at least in part on the first random number, the public key and a private key; - sending the authentication challenge to the legacy mobile terminal which can verify the origin of the authentication challenge based on a previously obtained bootstrapping server digital certificate associated with the bootstrapping server function; - receiving an authentication response at the bootstrapping server function that includes a second random number and a second parameter computed with a copy of the private key generated at the legacy mobile terminal based at least in part on the first random number and a pre-shared secret key stored in a subscriber identification module in the legacy mobile terminal; - verifying whether the authentication response originated from the legacy mobile terminal by re-computing the first parameter at the bootstrapping server function based on a second key provided to the bootstrapping server function; and - generating a mutually authenticated key at the bootstrapping server function based at least in part on the first random number the second random number and the private key. A method for authenticating a network application function to communicate with a legacy mobile terminal is also disclosed. The method comprises: - receiving an authentication challenge at the legacy mobile terminal, including a first random number as a first parameter, a public key based at least in part on the first random number, and a signature based at least in part on the first random number, the public key and a private key; - generating a mutually authenticated key at the legacy mobile terminal based at least in part on the first random number, a second random number and the private key; - verifying whether the authentication challenge originates at a bootstrapping server function based on a previously obtained bootstrapping server digital certificate associated with the bootstrapping server function; and - sending an authentication response to the bootstrapping server function that includes the second random number and a second parameter computed with a copy of the private key generated at the legacy mobile terminal based at least in part on the first random number and a pre-shared secret key stored in a subscriber identification module in the legacy mobile terminal.
Patent NZ-561009-A (NZ)
Title: Recombinant expression of defensins in filamentous fungi
Inventor: HOEGENHAUG HANS-HENRIK KRISTEN
Filed: 2006-03-14
Abstract: Provided is a method of recombinant expression of bactericidal arthropod defensin peptides in filamentous fungi. In particular, it has been found that the production of defensins can be improved significantly with the insertion of one or more intron sequences in a nucleic acid construct which directs expression of a defensin. The recombinant level may be improved by more than 50% compared to using a nucleic acid construct with no intron sequences. Particularly disclosed are filamentous fungal host cells, preferably an Aspergillus host cell, comprising a nucleic acid construct which comprises a nucleic acid sequence encoding a bactericidal arthropod defensin and one or more intron sequences.
Patent NZ-562839-A (NZ)
Title: Respiration detecting means including buckle with elastically deformable chamber
Inventor: LANG BERND
IPC: A61B5/113
Filed: 2006-04-24
Abstract: Disclosed is a detecting means for detecting a signal that is indicative of the activity of the respiratory muscles of a person to be examined. The detecting means comprising a band means (1) which, in use, is passed around a torso region which widens and narrows when the person to be examined breathes, as well as a structure that is included in the band means and loaded in accordance with the narrowing or widening. The structure is configured as a buckle (2) and is responsive to the load such that changes in the load cause a change in the volume of a measuring means (3) included in the buckle. The change in volume is caused by squeezing or widening an elastically deformable chamber means at a tube portion (4) thereof.
Patent NZ-563824-A (NZ)
Title: Quinoline derivatives as antibacterial agents
Inventor: ANDRIES KOENRAAD JOZEF LODENWIJK MARCEL
IPC: A61K31/47
Filed: 2006-06-06
Abstract: Disclosed is the use of the compound of formula (I), or a salt, stereoisomer, or N-oxide thereof, where the substituents are as defined in the specification, for treating a bacterial infection caused by Staphylococci, Enterococci, or Streptococci.
Patent NZ-565764-A (NZ)
Title: Oxygen indicator for use in medical products
Inventor: TROUILLY JEAN LUC
IPC: A61J1/00
Filed: 2006-08-02
Abstract: Disclosed is an oxygen indicator for detecting the presence of oxygen in a medical container, the oxygen indicator comprising: (a) greater than 6 and less than 60 g/L of indigo carmine; (b) a buffer to adjust the pH to a range of about 9.0 to about 9.75; (c) microcrystalline cellulose ranging from about 150 g/L to about 210 g/L (d) a reducing agent; (e) water; and (f) a colour of an oxidized form of the oxygen indicator being distinct from a colour of a reduced form of the oxygen indicator; wherein following sterilization by autoclaving the colour of the reduced form remains distinct from the colour of the oxidized form and the colour of the oxidized form remains distinct from the colour of the reduced form for at least six months at 40 degrees Celsius. Also disclosed is an oxygen indicating packet comprising said oxygen indicator.
Patent NZ-572392-A (NZ)
Title: Guava leaf extract powder and method for production thereof
Inventor: YOSHIKAWA MASAKI
IPC: A23L19/00
Filed: 2007-05-14
Abstract: Disclosed is a method for producing a guava leaf extract powder, comprising: (A) extracting guava leaves with hot water at 90 to 95 degrees C, to thereby produce an extract; (B) concentrating the extract to a Brix level of 20 to 30, to thereby form a concentrated extract; and (C) lyophilizing the concentrated extract.
Patent NZ-576162-A (NZ)
Title: Nitrogen containing substituted heterocycles as platelet adp receptor inhibitors
Inventor: SCARBOROUGH ROBERT M
IPC: C07D409/14
Filed: 2007-09-20
Abstract: Disclosed are compounds of formula (I) or pharmaceutically acceptable salts thereof, and methods for their synthesis. Examples of compounds of formula (I) include 2-(5-chlorothiophen-2-yl)-2-(5-(6-fluoro-7-(methylamino)-2,4-dioxo-1,2-dihydroquinazolin-3(4H)-yl)thiophene-2-carboxamido)acetic acid, N-((1H-tetrazol-5-yl)(m-tolyl)methyl)-4-(6-fluoro-7-(methylamino)-2,4-dioxo-1,2-dihydroquinazolin-3(4H)-yl)benzamide, and N-((5-chlorothiophen-2-yl)(1H-tetrazol-5-yl)methyl)-4-6-fluoro-7-(methylamino)-2,4-dioxo-1,2-dihydroquinazolin-3(4H)-yl)benzamide Also disclosed is the use of a compound of formula (I) for preventing or treating thrombosis and thrombosis related conditions, a condition or disorder mediated at least in part by adenosine diphosphate (ADP) - induced platelet aggregation.
Patent NZ-581365-A (NZ)
Title: Monoclonal antibodies against claudin-18 for treatment of a krukenberg tumor
Inventor: SAHIN UGUR
IPC: A61P35/00
Filed: 2008-05-27
Abstract: Disclosed is the use of an antibody having the ability of binding to CLD1SA2 and mediating killing and/or inhibition of proliferation of cells expressing CLD1SA2, for the preparation of a medicament for treating or preventing a Krukenberg tumour.
Patent NZ-582055-A (NZ)
Title: Food or cheese slicing device with support for the food to be sliced
Inventor: WALKER DAVID H
IPC: B26D1/06
Filed: 2008-05-30
Abstract: A food slicing device 10 comprises a container 11 for containing at least a portion of a food product for slicing, a movable slicer for slicing through a bottom end of the food product, driving means 17 to move the slicer, and supporting means 20 for supporting the weight of a food product contained within the container. The container 11 has an open bottom end, and is arranged so that a food product can be fed by gravity in a direction towards the bottom end. The food product is supported in a position in which the slicer can slice through the bottom end of the food product. The supporting means includes at least two supports. The first support 20 has a fixed position relative to the container. The second support moves with the slicer and is arranged to slide across a downward facing surface of the food product as the slicer slices through the food product. The supporting means is arranged so that as the slicer slices through the food product, the food product slice can fall away from the food product under gravity while the food product is still supported.
Patent NZ-592723-A (NZ)
Title: Cyclic pyrimidin-4-carboxamides as ccr2 receptor antagonists for treatment of inflammation, asthma and copd
Inventor: BUETTNER FRANK
IPC: A61K31/506
Filed: 2009-12-17
Abstract: Disclosed herein are cyclic pyrimidin-4-carboxamides of general formula (I), wherein the substituents are as defined in the specification, processes for their preparation, compositions comprising said compounds and uses thereof. Said compounds are useful as CCR2 receptor antagonists and as such are useful in the treatment of pulmonary diseases like asthma and COPD, neurologic disease, especially of pain diseases, immune related diseases, especially diabetes mellitus including diabetes nephropathy, and cardiovascular diseases, especially atherosclerotic disease.
Patent NZ-593968-A (NZ)
Title: System for conversion of aquatic wave energy into electrical energy
Inventor: DRAGIC MILE
IPC: F03B13/18
Filed: 2008-12-10
Abstract: 593968 A system for the conversion of aquatic wave energy of water into electrical energy comprises a floating body IIa adapted to float in water, a transmission member pivotally coupled to the floating body at point below the centre of gravity of the floating body IIa, conversion means to convert the generally linear movement of the transmission member into rotational movement, and a generator G to convert the rotational movement of the conversion means into electricity. The transmission member is adapted to move generally linearly in response to upward and downward movement of the floating body. The conversion means comprises a constant rotation mechanism and a multiplier to convert two direction linear movement into one direction rotational movement. The transmission member comprises linear gear teeth that are adapted to engage the teeth of an input gear.
Patent NZ-596804-A (NZ)
Title: A protective inhaler package made of a rigid enclosure casing with a void and a flexible enclosure casing
Inventor: BERRY SIMON
IPC: B65D75/32
Filed: 2008-11-07
Abstract: 596804 Disclosed is a pMDI inhaler package providing a protective enclosure. The package contains an inhaler and the protective enclosure comprises at least one rigid enclosure member comprising at least one flexible support member arranged to support the inhaler. The at least one rigid enclosure member comprises two rigid enclosure members that are formed from one sheet of rigid material that is folded or attached to each other, each defining an inhaler shaped recess to house a respective section of the inhaler. The inhaler is comprised of an elongate main body with a mouth piece extending in an essentially transverse direction with respect to the main body, and wherein the section of the inhaler housed within the recess defined by one of the two rigid enclosure members comprises essentially the whole mouth piece.
Patent NZ-598750-A (NZ)
Title: Therapeutic agent for mood disorders
Inventor: YAMADA KOJI
IPC: A61K31/426
Filed: 2010-09-02
Abstract: Disclosed is a therapeutic and/or prophylactic agent for depressive disorders, which contains a thiazole derivative represented by general formula (I) (wherein R1 represents an aryl group or the like, and R2 represents a pyridyl group or the like) or a pharmaceutically acceptable salt thereof as an active ingredient. In one embodiment the agent is N-[4-(2-furyl)-5-(tetrahydropyran-4-ylcarbonyl)thiazol-2-yl)]-6-methylpyridine-3-carboxamide (IC).
Patent NZ-602289-A (NZ)
Title: Fe(iii) complex compounds for the treatment and prophylaxis of iron deficiency symptoms and iron deficiency anemias
Inventor: KALOGERAKIS ARIS
IPC: A61P7/06
Filed: 2011-03-22
Abstract: IP No. 602289 The disclosure relates to iron(III) β-ketoamide complex compounds of formula I and pharmaceutical compounds comprising same for use as medicaments, in particular for the treatment and/or for the prophylaxis of iron deficiency symptoms and iron deficiency anemias. Compounds of the disclosure include: Tris-(3-oxobutaneamide)-iron(III) complex Tris-(N,N-dimethyl-3-oxobutaneamide)-iron(III) complex Tris-(N-methyl-3-oxobutaneamide)-iron(III) complex Tris(N-butyl-3-oxobutaneamide)-iron(III) complex Tris(N,N-dibutyl-3-oxobutaneamide)-iron(III) complex Tris-(1-(piperidin-1-yl)-butane-1,3-dione)-iron(III) complex Tris(3-oxoheptaneamide)-iron(III) complex Tris(N-methyl-3-oxoheptaneamide)-iron(III) complex Tris-(N,N-bis-(2-hydroxyethyl)-3-oxobutaneamide)-iron(III) complex Tris-(4-Methoxy-1-(morpholin-4-yl)butane-1,3-dione)-iron(III)-complex Tris-(3-acetyl-1-methylpyrrolidin-2-one)-iron(III)-complex Tris-(Ethyl (1-methyl-2-oxopyrrolidin-3-yl)(oxo)acetate)-iron(III)-complex Tris-(ethyl (1-methyl-2-oxopiperidin-3-yl)(oxo)acetate)-iron(III)-complex And Tris-(N-(2-hydroxypropyl)-3-oxobutanamide)-iron(III)-complex
Patent NZ-603614-A (NZ)
Title: Use of metformin in combination with a glucokinase activator and compositions comprising metformin and a glucokinase activator
Inventor: MJALLI ADNAN M M
IPC: C07D277/00
Filed: 2011-05-24
Abstract: Disclosed herein is the use of a glucokinase activator, in particular { 2-[3-cyclohexyl-3-(trans-4-propoxy-cyclohexyl)-ureido]-thiazol-5-ylsulfanyl} -acetic acid; in combination with an anti-diabetic drug, such as metformin, for the treatment of type 2 diabetes and other conditions such as lowering blood glucose enhancing phosphorylation and improving insulin sensitivity.
Patent NZ-606407-A (NZ)
Title: Asymmetric membranes comprising first and second asymmetric porous zones
Inventor: MARK MURLA
IPC: B01D67/00
Filed: 2013-01-30
Abstract: Asymmetric membranes comprising a first asymmetric porous zone including a first porous asymmetry that increases from the first exterior surface through the first porous zone of the bulk, and a second asymmetric porous zone including a second porous asymmetry that increases from the second exterior surface through the second porous zone of the bulk, wherein the first average pore size is larger than the second average pore size, as well as methods of making and using the membranes, are disclosed.
Patent NZ-611669-A (NZ)
Title: Soil treating system and shearing assembly
Inventor: LEIST JAMES R
IPC: A01G23/00
Filed: 2011-12-07
Abstract: A soil treating system and shearing assemblies (10) for use in forestry operations is disclosed. Embodiments of soil treating systems according to the disclosure include a movement assembly, such as a tractor (12), with a shearing assembly (22) mounted on its the front end. A levelling assembly (24) is mounted on the back end of the movement assembly. In some embodiments shearing assemblies are inverted V-type shearing assemblies. Further aspects of the disclosure are directed towards methods for using soil treating systems and shearing assemblies for preparing land for inter-planting an energy crop with a primary crop.
Patent NZ-613541-A (NZ)
Title: A fastening device for an attachment on a hard material supporting wall
Inventor: POURTIER FABRICE
IPC: H02G3/32
Filed: 2012-01-20
Abstract: Disclosed is an impact or gas charged or powder charged explosive fastening device that reduces impact forces transferred to the holding part from the nail or bolt fastener. The fastening device for an attachment on a hard material supporting wall comprises a holding part (2) for the attachment on the wall, a fastening nail (3) for the holding part, and a damping member for the absorption of the power generated by the tool. The shock absorbing or damping member is arranged between the fastening nail (3) and the holding part (2) so as to isolate one from the other.
Patent NZ-617623-A (NZ)
Title: Hydraulic pressure spring and method of manufacturing the same
Inventor: ARAMIZU TERUO
IPC: F16F9/32
Filed: 2008-01-17
Abstract: Disclosed is a compressible hydraulic fluid pressure spring that does not require a check valve but uses a threaded end to maintain cylinder pressure. The hydraulic pressure spring comprises a hollow cylindrical cylinder having a threaded portion at least one end thereof. One closure means threadedly engages with the threaded portion at the one end of the cylinder and closes the one end of the cylinder. Another closure means which is provided at another end of the cylinder, closes the other end of the cylinder. A compressible liquid is sealed in an interior of the cylinder and is pressurized to a predetermined pressure. A rod is passed through the one closure means movably in an axial direction and causes the liquid in the interior of the cylinder to undergo a pressure rise as the rod enters the interior of the cylinder. The liquid sealed in the interior of the cylinder is pressurized to a predetermined level by the threaded insertion of the one closure means into the threaded portion of the cylinder. The threaded portion of the cylinder is constituted by an internal thread formed on an inner peripheral surface of the cylinder at the one end thereof, and the one closure means includes a closure member which has on its outer peripheral surface an external thread threadedly engaged with the internal thread formed on the inner peripheral surface of the cylinder at the one end thereof. The closure member has a through hole, and a hollow cylindrical seal member secured to an inner peripheral surface defines the through hole of the closure member. The rod is passed through the seal member so that its outer peripheral surface is brought into contact with an inner peripheral surface of the seal member slidably in the axial direction, and wherein the closure member and the seal member close at the one end of the cylinder in co-operation with the rod passed through the seal member slidably in the axial direction.
Patent NZ-627997-A (NZ)
Title: Process for preparing infant formula
Inventor: VAN DEN BRENK JOEP
IPC: A23L33/00
Filed: 2013-03-13
Abstract: Disclosed is a process for preparing a lipid and protein component-containing composition, which is an infant or follow-on formula or a growing up milk and comprises lipid globules, comprising the steps of: a) providing an aqueous phase with a dry matter content of 10 to 60 wt.%, based on total weight of the aqueous phase, which comprises at least one protein component, b) providing a liquid lipid phase, which comprises at least one lipid and c) mixing the lipid phase with the aqueous phase in a ratio of 5 to 50 %, w/w using an inline mixer with at least one mixing head so as to obtain a lipid and protein component-containing composition comprising lipid globules.
Patent NZ-704786-A (NZ)
Title: Systems and methods for monitoring oil/gas separation processes
Inventor: TUNHEIM OLA
IPC: E21B43/34
Filed: 2013-09-10
Abstract: Disclosed are systems and method for analysing an oil/gas separation process. One disclosed system includes a flow path containing a fluid, the fluid including a desired characteristic, a fluid separator coupled to the flow path and having an inlet for receiving the fluid and a discharge conduit for discharging the fluid after having undergone a separation process in the fluid separator, an optical computing device having an integrated computational element configured to optically interact with electromagnetic radiation and the fluid before the fluid enters the fluid separator and after the fluid exits the fluid separator and thereby generate optically interacted light, the integrated computational element comprising a plurality of alternating layers of two materials having different index of refraction, the thickness of each layer and the number of layers being determined according to a spectral property of the electromagnetic radiation and a regression vector associated with the desired characteristic of the fluid, wherein a portion of the optically interacted light is transmitted through the integrated computational element; and at least on detector arranged to receive the optically interacted light and generate an output signal corresponding to a the desired characteristic of the fluid.
Patent NZ-705606-A (NZ)
Title: Methods for identifying antibodies with reduced immunogenicity
Inventor: HARDING FIONA A
IPC: G01N33/68
Filed: 2013-09-18
Abstract: The disclosure describes methods of identifying a variant of a reference antibody with reduced immunogenicity as compared to the reference antibody. The disclosure further describes variants of a reference anti-TNF-α antibody having reduced immunogenicity as compared to the reference anti-TNF-α reference antibody.